ENPAXSEM Trademark

Trademark Overview


On Tuesday, June 20, 2023, a trademark application was filed for ENPAXSEM with the United States Patent and Trademark Office. The USPTO has given the ENPAXSEM trademark a serial number of 98049964. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, October 21, 2024. This trademark is owned by Pfizer Inc.. The ENPAXSEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
enpaxsem

General Information


Serial Number98049964
Word MarkENPAXSEM
Filing DateTuesday, June 20, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Friday, June 23, 2023NEW APPLICATION ENTERED
Sunday, July 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 8, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU EXTENSION 1 FILED
Monday, October 21, 2024SOU EXTENSION 1 GRANTED